Kornevs Egils, Apse Ingus Arnolds, Safronovs Toms Janis, Krastina Aija, Paparde Arturs, Lauskis Gunars, Salms Girts
Department of Oral and Maxillofacial Surgery, Riga Stradiņš University, Riga, Latvia.
Stomatologija. 2020;22(1):9-16.
To test if there are different outcomes in basal cell carcinoma for lesion size, histopathology, localization, and recurrence rates.
A total of 395 patients with BCC localized in the neck, nose and ear regions who were surgically treated in Latvian Oncology Centre between 2006-2011 were analyzed retrospectively. The data were analyzed using modified classification based on Clarks et al. (2014) and McKenzie et al. (2016).
Three hundred and ninety-five cases of BCC that were surgically treated in head and neck region were reviewed. Results were tabulated in four categories: anatomical region, histopathology, lesion size, and recurrence rates. Classification by anatomical region: 228 cases in the nose region, 82 cases in the neck region, 82 cases in the ear region. Classification by histopathology: 259 cases presented as low risk BCC [nodular, pigmented, adenoid, keratotic and cystic], 21 cases presented as superficial, 94 cases presented as mixed, and 21 cases presented as high-risk BCC (metatypical, morphea form). Mann-Whitney U test was used to compare recurrent BCC cases to non-recurrent cases. Significantly higher recurrence rates were observed if BCC at the time of the excision was ≥10 mm (p<0.001). Significance was also noted in cases where histopathology was mixed BCC and in cases where mixed BCC was localized to the nose region (p<0.001).
More attention should be brought to assessing classification and clinical treatment synergy. Higher recurrence rates are observed when lesions occur in high risk anatomical region (H zone), when lesion size reaches or exceeds 20 mm in diameter, and when lesion is subtyped as mixed BCC. It is crucial to evaluate risk factors such as BCC subtype and localization, as these are associated with a higher rate of recurrence when present in a single lesion. These risk factors, together with pre-treatment lesion evaluation will enable formulation of better treatment plan and prognostic aspects in each case.
检验基底细胞癌在病灶大小、组织病理学、部位及复发率方面是否存在不同的结果。
回顾性分析2006年至2011年期间在拉脱维亚肿瘤中心接受手术治疗的395例颈部、鼻部和耳部基底细胞癌患者。数据采用基于克拉克等人(2014年)和麦肯齐等人(2016年)的改良分类法进行分析。
对395例头颈部接受手术治疗的基底细胞癌病例进行了回顾。结果分为四类:解剖部位、组织病理学、病灶大小和复发率。按解剖部位分类:鼻部228例,颈部82例,耳部82例。按组织病理学分类:259例为低风险基底细胞癌[结节状、色素沉着型、腺样、角化型和囊性],21例为浅表型,94例为混合型,21例为高风险基底细胞癌(化生型、硬斑病样)。采用曼-惠特尼U检验比较复发性基底细胞癌病例与非复发性病例。切除时基底细胞癌≥10 mm的病例复发率显著更高(p<0.001)。组织病理学为混合型基底细胞癌的病例以及混合型基底细胞癌位于鼻部的病例也具有显著性差异(p<0.001)。
应更加关注评估分类与临床治疗协同作用。当病灶发生在高风险解剖区域(H区)、病灶直径达到或超过20 mm以及病灶亚型为混合型基底细胞癌时,复发率更高。评估基底细胞癌亚型和部位等风险因素至关重要,因为这些因素在单个病灶中出现时与更高的复发率相关。这些风险因素以及治疗前病灶评估将有助于为每个病例制定更好的治疗方案和预后方案。